Confirmation of vesting date of share awards to directors and the company secretary and sale of unvested shares Mediclinic International Limited Incorporated in the Republic of South Africa Reg. no. 1983/010725/06 Income tax no: 9950122714 JSE Share code: MDC NSX share code: MCI ISIN code: ZAE000074142 (“Mediclinic” or “the Company”) CONFIRMATION OF VESTING DATE OF SHARE AWARDS TO DIRECTORS AND THE COMPANY SECRETARY OF MEDICLINIC AND SALE OF UNVESTED SHARES As previously announced on the Stock Exchange News Service (“SENS”) of the JSE Limited, in terms of paragraph 3.63 of the Listings Requirements, the following executive directors and the company secretary of Mediclinic have been granted and have accepted forfeitable or conditional share awards (“Awards”), as indicated below, in terms of the Mediclinic Forfeitable Share Plan (“FSP”), as approved by the Company’s shareholders at the annual general meeting held in July 2014. On 14 October 2015, Mediclinic announced the proposed combination of the businesses of Al Noor Hospitals Group plc (“Al Noor”) and Mediclinic (the “Combination”), to be effected by way of a scheme of arrangement in terms of the Companies Act 71 of 2008 (the “Scheme”). The Scheme has become unconditional, as announced on in the finalisation announcement released on SENS on 29 January 2016. In terms of the rules of the FSP, the Remuneration Committee of Mediclinic exercised its discretion to make such adjustments to the Awards as may be required as a result of the implementation of the Combination. With regard to the performance conditions attached to the FSP Awards, the extent to which the absolute total shareholder return (TSR) and normalised diluted headline earnings per share (HEPS) were achieved was tested by the Remuneration Committee as at 31 December 2015. As a result of this exercise, the following adjustments have been made: 1. 2014 Awards In respect of the Awards made in 2014, 100% of the performance conditions have been met. Accordingly, 100% of these Awards will vest on 31 May 2017, subject to the participants’ continued employment up to the vesting date. 2. 2015 Awards In respect of the Awards made in 2015, 78% of the performance conditions have been met. Accordingly, 78% of these Awards will vest on 31 May 2018, subject to the participants’ continued employment up to the vesting date. The remaining 22% of the Awards, having necessarily been forfeited (“Forfeiture”), have been sold by Mediclinic, as summarised below: Company : Mediclinic International Limited Nature of transaction : On-market sale of shares Date of sale : 29 January 2016 Number of securities : 45 733 Class of securities : Ordinary shares Selling price per share : Highest price: R120.45 Lowest price: R120.00 VWAP: R120.0833 Total value of transaction : R5 491 769.56 on acceptance Clearance obtained : Yes The FSP Awards received, forfeited and held by directors and the company secretary of Mediclinic, following the Forfeiture are as follows: Director : D P Meintjes Company : Mediclinic International Limited Number of 2014 Awards : 79 077 Vesting date of 2014 : 31 May 2017 Awards Number of 2015 Awards : 69 639 Number of 2015 Awards : 15 321 forfeited Vesting date of 2015 : 31 May 2018 Awards Balance of 2014 and 2015 : 133 395 Awards retained Director : C I Tingle Company : Mediclinic International Limited Number of 2014 Awards : 44 320 Vesting date of 2014 : 31 May 2017 Awards Number of 2015 Awards : 40 649 Number of 2015 Awards : 8 943 forfeited Vesting date of 2015 : 31 May 2018 Awards Balance of 2014 and 2015 : 76 026 Awards retained Director : K H S Pretorius Company : Mediclinic International Limited Number of 2014 Awards : 31 690 Vesting date of 2014 : 31 May 2017 Awards Number of 2015 Awards : 27 160 Number of 2015 Awards : 5 975 forfeited Vesting date of 2015 : 31 May 2018 Awards Balance of 2014 and 2015 : 52 875 Awards retained Director : C A van der Merwe Company : Mediclinic International Limited Number of 2014 Awards : 26 411 Vesting date of 2014 : 31 May 2017 Awards Number of 2015 Awards : 23 034 Number of 2015 Awards : 5 067 forfeited Vesting date of 2015 : 31 May 2018 Awards Balance of 2014 and 2015 : 44 378 Awards retained Company Secretary : G C Hattingh Company : Mediclinic International Limited Number of 2014 Awards : 23 575 Vesting date of 2014 : 31 May 2017 Awards Number of 2015 Awards : 20 705 Number of 2015 Awards : 4 555 forfeited Vesting date of 2015 : 31 May 2018 Awards Balance of 2014 and 2015 : 39 725 Awards retained Stellenbosch 1 February 2016 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 (0)21 809 6500 Fax +27 (0)21 886 4037 Ethics Line: 0800 005 316 (if dialling from South Africa) or ethics@mediclinic.com Website: www.mediclinic.com JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Proprietary) Limited Date: 01/02/2016 03:41:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.